Both in Pharmaceuticals
Nektar Therapeutics vs UroGen Pharma
Over the past year NKTR returned −35.7% and URGN returned +32.3%; their daily moves had a correlation of 0.17.
NKTR −35.7% URGN +32.3%Growth of $1, one year, split-adjusted
| Metric | NKTR | URGN |
|---|---|---|
| Price | $36.01 | $26.21 |
| Market cap | $1.23B | $1.29B |
| Today | −6.42% | −8.80% |
| 1 month | −10.6% | −35.6% |
| 6 months | −56.8% | −1.4% |
| Year to date | −14.8% | +11.9% |
| 1 year | −35.7% | +32.3% |
| Revenue growth (YoY) | −9.3% | +199.2% |
| Gross margin | 100.0% | 90.9% |
| Net margin | −401.0% | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | 22.5× | 6.8× |
| Net cash | $684.3M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 70.8% | 56.6% |
| Short % of float | 21.0% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).